Denlinger RH - Search Results

1

Evaluation of selective gamma-secretase inhibitor PF-03084014 for its antitumor efficacy and gastrointestinal safety to guide optimal clinical trial design.

Wei P, Walls M, Qiu M, Ding R, Denlinger RH, Wong A, Tsaparikos K, Jani JP, Hosea N, Sands M, Randolph S, Smeal T. Wei P, et al. Among authors: denlinger rh. Mol Cancer Ther. 2010 Jun;9(6):1618-28. doi: 10.1158/1535-7163.MCT-10-0034. Epub 2010 Jun 8. Mol Cancer Ther. 2010. PMID: 20530712

2

Intermittent oral coadministration of a gamma secretase inhibitor with dexamethasone mitigates intestinal goblet cell hyperplasia in rats.

Aguirre SA, Liu L, Hosea NA, Scott W, May JR, Burns-Naas LA, Randolph S, Denlinger RH, Han B. Aguirre SA, et al. Among authors: denlinger rh. Toxicol Pathol. 2014;42(2):422-34. doi: 10.1177/0192623313486315. Epub 2013 May 7. Toxicol Pathol. 2014. PMID: 23651588

3

Nonclinical safety evaluation of sunitinib: a potent inhibitor of VEGF, PDGF, KIT, FLT3, and RET receptors.

Patyna S, Arrigoni C, Terron A, Kim TW, Heward JK, Vonderfecht SL, Denlinger R, Turnquist SE, Evering W. Patyna S, et al. Toxicol Pathol. 2008 Dec;36(7):905-16. doi: 10.1177/0192623308326151. Epub 2008 Nov 3. Toxicol Pathol. 2008. PMID: 18981453

4

The propionic acids. Gastrointestinal toxicity in various species.

Elliott GA, Purmalis A, VanderMeer DA, Denlinger RH. Elliott GA, et al. Among authors: denlinger rh. Toxicol Pathol. 1988;16(2):245-50. doi: 10.1177/019262338801600217. Toxicol Pathol. 1988. PMID: 3142029 Review.

5

Chronic cardiotoxicity studies in rabbits with 7-con-O-methylnogarol, a new anthracycline antitumor agent.

McGovren JP, Neil GL, Denlinger RH, Hall TL, Crampton SL, Swenberg JA. McGovren JP, et al. Among authors: denlinger rh. Cancer Res. 1979 Dec;39(12):4849-55. Cancer Res. 1979. PMID: 498112 No abstract available.

6

Host factors affecting perinatal carcinogenesis by resorptive alkylnitrosoureas in rats.

Koestner A, Swenberg JA, Denlinger RH. Koestner A, et al. Among authors: denlinger rh. Natl Cancer Inst Monogr. 1979 May;(51):211-7. Natl Cancer Inst Monogr. 1979. PMID: 481574

7

Sequential development of ethylnitrosourea-induced neurinomas: morphology, biochemistry, and transplantability.

Swenberg JA, Clendenon N, Denlinger R, Gordon WA. Swenberg JA, et al. J Natl Cancer Inst. 1975 Jul;55(1):147-52. doi: 10.1093/jnci/55.1.147. J Natl Cancer Inst. 1975. PMID: 1159807

8

Induction of neurogenic tumors in C3HeB-FeJ mice by nitrosourea derivatives: observations by light microscopy, tissue culture, and electron microscopy.

Denlinger RH, Koestner A, Wechsler W. Denlinger RH, et al. Int J Cancer. 1974 Apr 15;13(4):559-71. doi: 10.1002/ijc.2910130416. Int J Cancer. 1974. PMID: 4366972 No abstract available.

9

Quantitative aspects of transplacental tumor induction with ethylnitrosourea in rats.

Swenberg JA, Koestner A, Wechsler W, Denlinger RH. Swenberg JA, et al. Among authors: denlinger rh. Cancer Res. 1972 Dec;32(12):2656-60. Cancer Res. 1972. PMID: 4345400 No abstract available.

10

Differential effect of immunosuppression on the induction of nervous system and bladder tumors by N-methyl N-nitrosourea.

Denlinger RH, Swenberg JA, Koestner A, Wechsler W. Denlinger RH, et al. J Natl Cancer Inst. 1973 Jan;50(1):87-93. doi: 10.1093/jnci/50.1.87. J Natl Cancer Inst. 1973. PMID: 4692871 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters